Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 03    symbols : Fulc    save search
Fulcrum Therapeutics® Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
BMY | $49.14 0.43% 0.0% 7.9M twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 1.15% C: 0.38%
FULC | $7.26 6.14% 5.79% 600K twitter stocktwits trandingview |
Health Technology
 | | O: -1.71% H: 10.39% C: 7.24%
therapeutics financial results report results
Fulcrum Therapeutics® Announces REACH, a Phase 3 Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
FULC | $7.26 6.14% 5.79% 600K twitter stocktwits trandingview |
Health Technology
 | | O: -1.71% H: 10.39% C: 7.24%
therapeutics muscular dystrophy trial phase 3
Gainers vs Losers
75% 25%

Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M twitter stocktwits trandingview |

AGBA | $2.565 105.2% 51.27% 200M twitter stocktwits trandingview |
Finance
MLEC | $2.44 74.29% 42.62% 78M twitter stocktwits trandingview |
n/a
EDBL | News | $6.28 67.02% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.91 48.81% 32.8% 180K twitter stocktwits trandingview |

ZAPP | $0.2175 47.16% 32.05% 16M twitter stocktwits trandingview |
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M twitter stocktwits trandingview |
n/a
VIVK | $1.48 38.32% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M twitter stocktwits trandingview |

SDIG A | $3.635 35.13% 26.0% 1M twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.